OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Sunitinib increases the cancer stem cells and vasculogenic mimicry formation via modulating the lncRNA-ECVSR/ERβ/Hif2-α signaling
Miao He, Huan Yang, Hangchuan Shi, et al.
Cancer Letters (2021) Vol. 524, pp. 15-28
Closed Access | Times Cited: 34
Miao He, Huan Yang, Hangchuan Shi, et al.
Cancer Letters (2021) Vol. 524, pp. 15-28
Closed Access | Times Cited: 34
Showing 26-50 of 34 citing articles:
LINC00645 inhibits renal cell carcinoma progression by interacting with HNRNPA2B1 to regulate the ROCK1 mRNA stability
Hao Li, Han Xu, Liang Song, et al.
Gene (2024) Vol. 905, pp. 148232-148232
Closed Access | Times Cited: 1
Hao Li, Han Xu, Liang Song, et al.
Gene (2024) Vol. 905, pp. 148232-148232
Closed Access | Times Cited: 1
Exploring vasculogenesis in the normal human kidney and clear cell renal cell carcinoma: insights from development to tumor progression and biomarkers for therapy response
Andrei Alexandru Cosma, Mihaela Pasca Fenesan, Alexandru Neşiu, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 1
Andrei Alexandru Cosma, Mihaela Pasca Fenesan, Alexandru Neşiu, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 1
The influence of sex hormones on renal cell carcinoma
Michael Ladurner, Andrea Katharina Lindner, Peter Rehder, et al.
Therapeutic Advances in Medical Oncology (2024) Vol. 16
Open Access | Times Cited: 1
Michael Ladurner, Andrea Katharina Lindner, Peter Rehder, et al.
Therapeutic Advances in Medical Oncology (2024) Vol. 16
Open Access | Times Cited: 1
The mechanistic immunosuppressive role of the tumour vasculature and potential nanoparticle-mediated therapeutic strategies
Zakaria Elias Ileiwat, Tanveer A. Tabish, Д. А. Зиновкин, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 6
Zakaria Elias Ileiwat, Tanveer A. Tabish, Д. А. Зиновкин, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 6
Endocrine nuclear receptors and long non‑coding RNAs reciprocal regulation in cancer (Review)
Monica Cantile, Margherita Cerrone, Maurizio Di Bonito, et al.
International Journal of Oncology (2023) Vol. 64, Iss. 1
Open Access | Times Cited: 3
Monica Cantile, Margherita Cerrone, Maurizio Di Bonito, et al.
International Journal of Oncology (2023) Vol. 64, Iss. 1
Open Access | Times Cited: 3
Long non-coding RNA HOXB-AS1 is a prognostic marker and promotes hepatocellular carcinoma cells’ proliferation and invasion
Yubin Chen, Na Wang, Liangqi Cao, et al.
Open Life Sciences (2022) Vol. 17, Iss. 1, pp. 944-951
Open Access | Times Cited: 5
Yubin Chen, Na Wang, Liangqi Cao, et al.
Open Life Sciences (2022) Vol. 17, Iss. 1, pp. 944-951
Open Access | Times Cited: 5
Long Non-Coding RNAs, Nuclear Receptors and Their Cross-Talks in Cancer—Implications and Perspectives
Prabha Tiwari, Lokesh P. Tripathi
Cancers (2024) Vol. 16, Iss. 16, pp. 2920-2920
Open Access
Prabha Tiwari, Lokesh P. Tripathi
Cancers (2024) Vol. 16, Iss. 16, pp. 2920-2920
Open Access
The role of N6-methyladenosine modification in tumor angiogenesis
Qin Li, Xinya Zeng, Xinze Qiu, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access
Qin Li, Xinya Zeng, Xinze Qiu, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access
Roles of enhancer RNAs in sex hormone-dependent cancers
Lu Zhang, Xiaoxia Ye, Jieyi Luo, et al.
Journal of Cancer Research and Clinical Oncology (2022) Vol. 148, Iss. 2, pp. 293-307
Closed Access | Times Cited: 1
Lu Zhang, Xiaoxia Ye, Jieyi Luo, et al.
Journal of Cancer Research and Clinical Oncology (2022) Vol. 148, Iss. 2, pp. 293-307
Closed Access | Times Cited: 1
